Clinical Expressway ensures you reach this milestone by bringing together Benuvia’s formulation, analytical, and regulatory expertise to remove obstacles and pave a direct route to clinical readiness. From producing clinical trial materials to meeting strict compliance standards, we handle the complexities so you can focus on advancing your science. With Clinical Expressway, your journey to the clinic is as efficient and stress-free as possible.
Benuvia has been a game-changer for our trial readiness. Their seamless integration of comparator sourcing, ancillary supply management, and blinding processes ensured our clinical materials were delivered on time and met the highest regulatory standards. The team’s expertise and proactive approach kept our trial on schedule and gave us confidence every step of the way.
Global Biopharma Company
Clinical Operations Director
Dr. Aruna Earla serves as the Director of the Research and Development group at Benuvia Operations, where she has been working since 2020. She is involved in the process development of Active Pharmaceutical Ingredients (APIs). With approximately 20 years of experience in pharmaceutical research, development, and manufacturing within the CRO and CDMO sectors, Dr. Earla brings a wealth of expertise to her role. She holds an M.S. in Organic Chemistry, an M.S. in Biotechnology, and a Ph.D. in Organic Chemistry. Her extensive experience in organic synthesis covers a wide range of chemistries, including cannabinoids and psychedelics. Dr. Earla’s contributions are significant, spanning from initial route scouting to the commercial manufacturing of APIs. Before joining Benuvia, she held Research Scientist positions at Alembic, Dr. Reddy’s, Olon-Ricerca Biosciences, and Nanosyn.
"*" indicates required fields